David Pomerantz, MD
Dermatology · Pawtucket, RINPI 1972529832
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 1,311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,311 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$3K
- Novartis$2K
- LEO Pharma Inc.$2K
- Lilly USA, LLC$2K
- Amgen$2K
- plus $10K from 34 others
What the payments were for
- Food & beverage$24,82098%
- Education$3942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,214 in reported general payments places this provider in the 90th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $76,283 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 244 | $8,708 |
| Ketoconazole | 232 | $4,639 |
| Triamcinolone Acetonide | 253 | $2,652 |
| Clobetasol Propionate | 40 | $2,355 |
| ValacyclovirValacyclovir Hcl | 44 | $1,671 |
| Clindamycin Phosphate | 16 | $1,367 |
| Metronidazole | 27 | $1,105 |
| Doxycycline Monohydrate | 23 | $1,086 |
| Glycopyrrolate | 12 | $1,064 |
| Ammonium Lactate | 43 | $1,049 |
| Doxycycline Hyclate | 24 | $1,041 |
| Minocycline Hcl | 41 | $971 |
| Minoxidil | 46 | $672 |
| Betamethasone Dipropionate | 17 | $602 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pawtucket
- Paul ZaydonPawtucket$4K
- Neil TobackPawtucket$3K
- John KellyEast Greenwich$97K
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Carlos WambierSouth Kingstown$41K
- Abrar QureshiProvidence$38K
- Gary WatermanMiddletown$16K
- Hua ZhouCranston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.